04/23/2024
4:30 PM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Galitzer Hillel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
4:32 PM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Yaacov-Garbeli Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
7:30 AM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
11:15 PM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form EFFECT | |
02/14/2024
5:05 AM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form S-3/A | |
02/02/2024
3:17 PM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/02/2024
3:19 PM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/16/2024
9:45 AM | Entera Bio (Subject)
Entera Bio Ltd. (Subject)
Knoll Capital Management, LLC (Filed by)
| Form SC 13G/A | |
01/16/2024
7:00 AM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Taitel Haya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:14 PM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Taitel Haya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
5:59 PM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Taitel Haya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:12 PM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
LIEBERMAN GERALD M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:15 PM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Mayron Ron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
7:00 AM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
4:19 PM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/27/2023
4:00 PM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
LIEBERMAN GERALD M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
7:27 AM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Toledano Miranda Jayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
7:00 AM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
4:02 PM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Toledano Miranda Jayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
4:03 PM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Taitel Haya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
3:05 PM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
7:11 AM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Taitel Haya (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/24/2023
7:12 AM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
Taitel Haya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
8:28 AM | Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
LIEBERMAN GERALD M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
8:20 AM | Ellis Sean (Reporting)
Entera Bio (Issuer)
Entera Bio Ltd. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:15 AM | Entera Bio (Subject)
Entera Bio Ltd. (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE/A | |
06/27/2023
3:05 PM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
3:05 PM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form PRE 14A | |
06/07/2023
6:30 AM | Entera Bio (Filer)
Entera Bio Ltd. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
